Laura Faivre

Androgen deprivation therapy plus docetaxel and estramustine versus androgen deprivation therapy alone for high-risk localised prostate cancer (GETUG 12): a phase 3 randomised controlled trial

Karim Fizazi, Laura Faivre, F. Lesaunier et al. · The Lancet Oncology · 2015 · 238 citations

Medicine, Oncology, Urology +17

LKB1/STK11 mutations in non-small cell lung cancer patients: Descriptive analysis and prognostic value

Francesco Facchinetti, M.V. Bluthgen, Gabrielle Tergemina-Clain et al. · Lung Cancer · 2017 · 113 citations

Medicine, Genetics, Oncology +10

TPF induction chemotherapy increases PD-L1 expression in tumour cells and immune cells in head and neck squamous cell carcinoma

Julien Adam, Émilie Louvet, Tony Sourisseau et al. · ESMO Open · 2018 · 91 citations · Full text

Medicine, Immunology, Oncology +16

Crizotinib in patients with advanced ROS1-rearranged non-small cell lung cancer (NSCLC). Preliminary results of the ACSé phase II trial.

Denis Moro‐Sibilot, Laura Faivre, Gérard Zalcman et al. · Journal of Clinical Oncology · 2015 · 47 citations

Medicine, Oncology, Pharmacology +17

Randomized trial comparing two methods of re-irradiation after salvage surgery in head and neck squamous cell carcinoma: Once daily split-course radiotherapy with concomitant chemotherapy or twice daily radiotherapy with cetuximab

Yungan Tao, Laura Faivre, Anne Laprie et al. · Radiotherapy and Oncology · 2018 · 40 citations

Medicine, Oncology, Radiation Oncology +5